RE:Cancer treatment is on forefront in USThey're using the DARPA/Internet example whicn sounds great but isn't that easy. I've never felt there isn't already a very high commercial incentive for exploring cures for hard to treat diseases. It's just that it takes time. mRNA research started in 1989, so it wasn't really used for the first 30 years while it was perfected.
The problem with partnering with somethiing like this is they will want some ownership, which THTX will not want to give them because their actual science is already understood and being tested. Further, THTX is actually moving pretty darn fast with the SORT1 platform in my view and doesn't really need outside money to complete the Phase 1 and start in to a Phase 2 possibly. Maybe the ATM offering or something else occurs once the science and commercial potential is clearer to the market. Raising money should be easy if there's a POC coming.
JayjayUSA12007 wrote:
https://degette.house.gov/media-center/press-releases/degette-upton-introduce-highly-anticipated-cures-20-bill
This agency should be informed of Thera efforts on Sortilin. It would either partner or fund the effort to speed up development.